First Class Post-Graduate MSc Degree in Life Sciences (Microbiology/ Biotechnology/ Biochemistry etc). Hands on experience in plant tissue culture. Proficiency in Western blotting, PCR and microbial culture.
B.S. 4 years programme, BPharm, Integrated BS-MS, MSc, BE, BTech or equivalent degree in Chemistry, Chemical Sciences, with 55% marks and passing of NET, GATE test with valid score card.
M.Sc in Chemistry / Applied Chemistry / Organic Chemistry / Polymer Chemistry / Materials Science or equivalent from recognized University or Equivalent and 3 years of experience in R&D in Industrial and Academic Institutions.
Anixa Biosciences, Inc., a clinical-stage biotechnology company specializing in cancer treatment and prevention, has announced the issuance of a new U.S. patent for its chimeric antigen receptor-T cell (CAR-T) technology.
Zydus Lifesciences Limited reported a steady performance for the quarter ended June 30, 2025, with growth across key geographies and strong contributions from innovation-driven initiatives. The pharmaceutical major posted revenue from operations of Rs. 65,737 million, marking a 6% increase year-on-year and a marginal 0.7% rise from the previous quarter. Net profit stood at Rs. 14,668 million, up 3% from the same quarter last year and a robust 25.3% higher than Q4 FY25.